KeyBanc raises Corteva stock target to $72, maintains Overweight

On Friday, KeyBanc Capital Markets adjusted its price target for shares of Corteva Inc. (NYSE:CTVA), increasing it to $72 from the previous $71, while reiterating an Overweight rating on the stock. The stock, currently trading at $66.86, has shown strong momentum with a 17.7% year-to-date return. According to InvestingPro data, analysts maintain a bullish consensus with price targets ranging from $59 to $80. The firm’s analysts highlighted Corteva’s strong first-quarter performance, which they believe could lead to annual results at the higher end of the company’s guidance for 2025.

Corteva’s first quarter was marked by several positive developments, including an uptick in corn and soybean seed pricing, which rose by 2-3%. Additionally, the company saw a 5% increase in crop protection volumes and benefited from reduced costs, including lower raw material expenses and improved productivity. These factors contributed to a robust start to the year and provided a strong foundation for Corteva’s 2025 outlook. InvestingPro analysis shows the company maintains a "GOOD" overall financial health score, with particularly strong marks in profitability and price momentum.

Despite these positive trends, KeyBanc noted a downward shift in the crop protection pricing outlook for 2025, moving from flat to a slight decrease. Nevertheless, the analysts remain confident in Corteva’s overall business strategy and its position as a core holding for investors. They pointed out that while Corteva’s leverage to the crop protection recovery is less than its peer FMC (NYSE:FMC), the company’s more stable seed business and stronger balance sheet make it an attractive option at the current juncture. The company operates with a moderate debt level and has demonstrated commitment to shareholder returns, having raised its dividend for six consecutive years.

In their commentary, KeyBanc analysts expressed their continued optimism about Corteva’s long-term growth strategy. They emphasized that the company’s solid performance in the first quarter has de-risked its 2025 guidance, with results likely to be at the top of the projected range. The analysts concluded by maintaining their positive Overweight rating and raising the price target to $72, reflecting their confidence in Corteva’s stronger earnings potential. Based on InvestingPro’s comprehensive analysis, which includes over 30 key metrics and financial indicators available to subscribers, Corteva appears to be trading near its Fair Value. Investors can access detailed valuation analysis, additional ProTips, and a complete financial health assessment through InvestingPro’s in-depth research report.

In other recent news, Corteva Inc. reported impressive first-quarter 2025 financial results, significantly exceeding earnings expectations. The company posted an earnings per share (EPS) of $1.13, surpassing the projected $0.88, and reported revenues of $4.61 billion, which also exceeded the anticipated $4.54 billion. Corteva’s performance was bolstered by a 15% increase in EBITDA and nearly 400 basis points of margin expansion. The company has maintained its full-year operating EBITDA guidance at $3.7 billion, with plans to introduce approximately 500 new products in 2025. Furthermore, Corteva is strategizing to mitigate a potential $50 million impact from trade policies and tariffs. The company remains optimistic about its growth platforms, including the launch of new seed hybrids and crop protection products, which are expected to drive future growth. Analyst discussions highlighted Corteva’s strategic initiatives and the company’s focus on innovation to enhance its competitive position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.